Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Uterine cyclin A2–deficient mice as a model of female early pregnancy loss
Fatimah Aljubran, Katelyn Schumacher, Amanda Graham, Sumedha Gunewardena, Courtney Marsh, Michael Lydic, Kristin Holoch, Warren B. Nothnick
Fatimah Aljubran, Katelyn Schumacher, Amanda Graham, Sumedha Gunewardena, Courtney Marsh, Michael Lydic, Kristin Holoch, Warren B. Nothnick
View: Text | PDF
Research Article Reproductive biology

Uterine cyclin A2–deficient mice as a model of female early pregnancy loss

  • Text
  • PDF
Abstract

Proper action of the female sex steroids 17β-estradiol (E2) and progesterone (P4) on the endometrium is essential for fertility. Beyond its role in regulating the cell cycle, cyclin A2 (CCNA2) also mediates E2 and P4 signaling in vitro, but a potential role in modulating steroid action for proper endometrial tissue development and function is unknown. To fill this gap in our knowledge, we examined human endometrial tissue from fertile and infertile cisgender women for CCNA2 expression and correlated this with pregnancy outcome. Functional assessment of CCNA2 was validated in vivo using a conditional Ccna2 uterine-deficient mouse model, while in vitro function was assessed using human cell culture models. We found that CCNA2 expression was significantly reduced in endometrial tissue, specifically the stromal cells, from women undergoing in vitro fertilization who failed to achieve pregnancy. Conditional deletion of Ccna2 from mouse uterine tissue resulted in an inability to achieve pregnancy, which appeared to be due to alterations in the process of decidualization, which was confirmed using in vitro models. From these studies, we conclude that CCNA2 expression during the proliferative/regenerative stage of the menstrual cycle allows for proper steroid responsiveness, decidualization, and pregnancy. When CCNA2 expression levels are insufficient, there is impaired endometrial responsiveness, aberrant decidualization, and loss of pregnancy.

Authors

Fatimah Aljubran, Katelyn Schumacher, Amanda Graham, Sumedha Gunewardena, Courtney Marsh, Michael Lydic, Kristin Holoch, Warren B. Nothnick

×

Figure 7

CCNA2 expression in human and mouse uterine stromal cells and uterine tissue prior to and during decidualization.

Options: View larger image (or click on image) Download as PowerPoint
CCNA2 expression in human and mouse uterine stromal cells and uterine ti...
(A–C) qRT-PCR assessment of (A) CCNA2, (B) PRL, and (C) IGFBP1 transcript expression during in vitro decidualization in nontransfected t-HESCs. (D) Ccna2 expression prior to and during late decidualization in mouse uterine tissue. Data are normally distributed and analyzed by 1-way ANOVA followed by Bonferroni’s post-hoc analysis. Different letters indicate statistical significance among the groups. In D, a versus b = P < 0.001. P < 0.001 for n =6 mice for dpc 0.5 and 2.5 and n = 5 mice for dpc 6.5. (E–G) qRT-PCR analysis of (E) CCNA2, (F) PRL, and (G) IGFBP1 transcript expression in NT-siRNA and CCNA2-siRNA transfected t-HESC prior to (day 0), and after a decidualization stimulus. Different block letters indicate statistical significance among the means across days of culture/treatment groups for NT-siRNA-transfected cells while different letters in italics indicate statistically significant differences among the means in the CCNA2-siRNA-transfected cells using 1-way ANOVA followed by Tukey-Kramer multiple comparison tests. In E, a versus b = P < 0.001. a versus b = P < 0.001; in F, a versus b = P < 0.001, a versus c = P < 0.001, b versus c = P < 0.001; a versus b = P < 0.001, a versus c = P < 0.001, b versus c = P < 0.01; in G, a versus b = P < 0.001, a versus c = P < 0.001, b versus c = P < 0.001; a versus b = P < 0.001, a versus c = P < 0.001, b versus c = P < 0.05. ***P < 0.001 between transfection groups within each time point using unpaired, 2-tailed t tests. For Figure 7, B and C, as well as Figure 7, E and F, values are expressed as the log10 value of the FC from the appropriate control for each transcript. Data are from 4 separate experiments (n = 4 replicates with different cell passage numbers). Within each graph of the box and whisker plot, X indicates the mean values while the whisker end points indicate the highest and lowest values.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts